Leukemic evolution of donor-derived cells harboring IDH2 and DNMT3A mutations after allogeneic stem cell transplantation.
1] Department of Cellular Signaling, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan [2] Department of Hematology and Oncology, Graduate School of Medicine, Nagoya University, Aichi, Japan.
T
T
Yasuda
Department of Cellular Signaling, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
T
T
Ueno
Department of Cellular Signaling, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
K
K
Fukumura
Department of Cellular Signaling, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
A
A
Yamato
Department of Cellular Signaling, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
M
M
Ando
Department of Cellular Signaling, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
H
H
Yamaguchi
Department of Cellular Signaling, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
M
M
Soda
Department of Medical Genomics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
M
M
Kawazu
Department of Medical Genomics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
E
E
Sai
Department of Medical Genomics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Y
Y
Yamashita
Department of Hematology and Oncology, Graduate School of Medicine, Nagoya University, Aichi, Japan.
M
M
Murata
Department of Hematology and Oncology, Graduate School of Medicine, Nagoya University, Aichi, Japan.
H
H
Kiyoi
1] Department of Hematology and Oncology, Graduate School of Medicine, Nagoya University, Aichi, Japan [2] National Hospital Organization Nagoya Medical Center, Aichi, Japan.
T
T
Naoe
1] Department of Cellular Signaling, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan [2] CREST, Japan Science and Technology Agency, Saitama, Japan.
H
H
Mano
D004248:DNA (Cytosine-5-)-Methyltransferases / Q000235:genetics*; D000090205:DNA Methyltransferase 3A; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects*; D006801:Humans; D007521:Isocitrate Dehydrogenase / Q000235:genetics*; D007938:Leukemia / Q000175:diagnosis / Q000209:etiology*; D008297:Male; D008875:Middle Aged; D009154:Mutation; D014019:Tissue Donors; D014184:Transplantation, Homologous
C000717967:DNMT3A protein, human; C538784:IDH2 protein, human; D007521:Isocitrate Dehydrogenase; D004248:DNA (Cytosine-5-)-Methyltransferases; D000090205:DNA Methyltransferase 3A